M. Pasparakis and P. Vandenabeele, Necroptosis and its role in inflammation, Nature, vol.517, pp.311-320, 2015.

Y. Muto, K. T. Nouri-aria, A. Meager, G. J. Alexander, A. L. Eddleston et al., Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure, Lancet, vol.2, pp.72-74, 1988.

G. L. Bird, N. Sheron, A. K. Goka, G. J. Alexander, and R. S. Williams, Increased plasma tumor necrosis factor in severe alcoholic hepatitis, Ann Intern Med, vol.112, pp.917-920, 1990.

S. Morioka, P. Broglie, E. Omori, Y. Ikeda, G. Takaesu et al., TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation, J Cell Biol, vol.204, pp.607-623, 2014.

M. A. Kelliher, S. Grimm, Y. Ishida, F. Kuo, B. Z. Stanger et al., The death domain kinase RIP mediates the TNF-induced NF-kappaB signal, Immunity, vol.8, pp.297-303, 1998.

S. B. Berger, V. Kasparcova, S. Hoffman, B. Swift, L. Dare et al., Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice, J Immunol, vol.192, pp.5476-5480, 2014.

N. Takahashi, L. Vereecke, M. J. Bertrand, L. Duprez, S. B. Berger et al., RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis, Nature, vol.513, pp.95-99, 2014.

M. Dannappel, K. Vlantis, S. Kumari, A. Polykratis, C. Kim et al., RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis, Nature, vol.513, pp.90-94, 2014.

J. E. Roderick, N. Hermance, M. Zelic, M. J. Simmons, A. Polykratis et al., Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis, Proc Natl Acad Sci, vol.111, pp.14436-14441, 2014.

G. Tiegs, J. Hentschel, and A. A. Wendel, T cell-dependent experimental liver injury in mice inducible by concanavalin A, J Clin Invest, vol.90, pp.196-203, 1992.

M. I. Arshad, M. Rauch, L. 'helgoualc'h, A. , J. V. Leite-de-moraes et al., NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis, Eur J Immunol, vol.41, pp.2341-2348, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00681990

Y. Watanabe, M. Morita, and T. Akaike, Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury, Hepatology, vol.24, pp.702-710, 1996.

Y. Tagawa, S. Kakuta, and Y. Iwakura, Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis, Eur J Immunol, vol.28, pp.4105-4113, 1998.

S. Kusters, G. Tiegs, L. Alexopoulou, M. Pasparakis, E. Douni et al., In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis, Eur J Immunol, vol.27, pp.2870-2875, 1997.

S. Jouan-lanhouet, M. I. Arshad, C. Piquet-pellorce, C. Martin-chouly, L. Moigne-muller et al., TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation, Cell Death Differ, vol.19, pp.2003-2014, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00871432

Y. Zhou, W. Dai, C. Lin, F. Wang, L. He et al., Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice, Mediators Inflamm, vol.2013, pp.1-15, 2013.

C. Kellendonk, C. Opherk, K. Anlag, G. Schütz, and F. Tronche, Hepatocyte-specific expression of Cre recombinase, Genesis, vol.26, pp.151-153, 2000.

M. I. Arshad, C. Piquet-pellorce, A. Filliol, L. 'helgoualc'h, A. Lucas-clerc et al., The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver, J Mol Med, vol.93, pp.867-878, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01134319

L. Houseman, M. Edwards, I. R. Phillips, and E. A. Shephard, Isolation and culture of mouse hepatocytes: gender-specific gene expression responses to chemical treatments, Methods Mol Biol, vol.1250, pp.3-12, 2015.

M. Sato and M. Tanigawa, Production of CETD transgenic mouse line allowing ablation of any type of specific cell population, Mol Reprod Dev, vol.72, pp.54-67, 2005.

A. Degterev, J. L. Maki, and J. Yuan, Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase, Cell Death Differ, vol.20, p.366, 2013.

N. Takahashi, L. Duprez, S. Grootjans, A. Cauwels, W. Nerinckx et al., Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models, Cell Death Dis, vol.3, p.437, 2012.

I. E. Gentle, W. W. Wong, J. M. Evans, A. Bankovacki, W. D. Cook et al., TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8, J Biol Chem, vol.286, pp.13282-13291, 2011.

Y. Estornes, M. A. Aguileta, C. Dubuisson, D. Keyser, J. Goossens et al., RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions, Cell Death Dis, vol.5, p.1555, 2014.
DOI : 10.1038/cddis.2014.523
URL : https://www.nature.com/articles/cddis2014523.pdf

H. Mizuhara, E. O'neill, N. Seki, T. Ogawa, C. Kusunoki et al., T cell activationassociated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6, J Exp Med, vol.179, pp.1529-1537, 1994.
DOI : 10.1084/jem.179.5.1529
URL : http://jem.rupress.org/content/179/5/1529.full.pdf

F. Gantner, M. Leist, A. W. Lohse, P. G. Germann, and G. Tiegs, Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor, Hepatology, vol.21, pp.190-198, 1995.

D. J. Van-antwerp, S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma, Suppression of TNF-alphainduced apoptosis by NF-kappaB, Science, vol.274, pp.787-789, 1996.

C. Liedtke and C. Trautwein, The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer, Eur J Cell Biol, vol.91, pp.582-589, 2012.

A. Kawasuji, M. Hasegawa, M. Horikawa, T. Fujita, Y. Matsushita et al., L-selectin and intercellular adhesion molecule-1 regulate the development of concanavalin A-induced liver injury, J Leukoc Biol, vol.79, pp.696-705, 2006.

D. Wolf, R. Hallmann, G. Sass, M. Sixt, S. Kusters et al., TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis, J Immunol, vol.166, pp.1300-1307, 2001.

G. Tiegs, M. Wolter, and A. Wendel, Tumor necrosis factor is a terminal mediator in galactosamine/ endotoxin-induced hepatitis in mice, Biochem Pharmacol, vol.38, pp.627-631, 1989.
DOI : 10.1016/0006-2952(89)90208-6

F. Geisler, H. Algül, S. Paxian, and R. M. Schmid, Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro, Gastroenterology, vol.132, pp.2489-2503, 2007.

R. Wroblewski, M. Armaka, V. Kondylis, M. Pasparakis, H. Walczak et al., Opposing role of tumor necrosis factor receptor 1 signaling in T cell-mediated hepatitis and bacterial infection in mice, Hepatology, vol.64, pp.508-521, 2016.

N. Festjens, T. Vanden-berghe, S. Cornelis, and P. Vandenabeele, RIP1, a kinase on the crossroads of a cell's decision to live or die, Cell Death Differ, vol.14, pp.400-410, 2007.

G. Kunstle, H. Hentze, P. G. Germann, G. Tiegs, T. Meergans et al., Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation, Hepatology, vol.30, pp.1241-1251, 1999.

Y. Dondelinger, M. A. Aguileta, V. Goossens, C. Dubuisson, S. Grootjans et al., RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition, Cell Death Differ, vol.20, pp.1381-1392, 2013.

A. T. Ting and M. J. Bertrand, More to life than NF-kappaB in TNFR1 signaling, Trends Immunol, vol.37, pp.535-545, 2016.
DOI : 10.1016/j.it.2016.06.002
URL : http://europepmc.org/articles/pmc5076853?pdf=render

C. Liedtke, J. M. Bangen, J. Freimuth, N. Beraza, D. Lambertz et al., Loss of caspase8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury, Gastroenterology, vol.141, pp.2176-2187, 2011.
DOI : 10.1053/j.gastro.2011.08.037

M. Vucur, F. Reisinger, J. Gautheron, J. Janssen, C. Roderburg et al., RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8-and JNK-dependent compensatory cell proliferation, Cell Rep, vol.4, pp.776-790, 2013.
DOI : 10.1016/j.celrep.2013.07.035
URL : https://doi.org/10.1016/j.celrep.2013.07.035

V. Kondylis, A. Polykratis, H. Ehlken, L. Ochoa-callejero, B. K. Straub et al., NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis, Cancer Cell, vol.28, pp.582-598, 2015.
DOI : 10.1016/j.ccell.2015.11.007
URL : https://doi.org/10.1016/j.ccell.2015.11.007

W. W. Wong, I. E. Gentle, U. Nachbur, H. Anderton, D. L. Vaux et al., RIPK1 is not essential for TNFR1-induced activation of NF-kappaB, Cell Death Differ, vol.17, pp.482-487, 2010.
DOI : 10.1038/cdd.2009.178
URL : https://www.nature.com/articles/cdd2009178.pdf

J. An, F. Mehrhof, C. Harms, G. Lattig-tunnemann, S. L. Lee et al., ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosis, J Hepatol, vol.58, pp.297-305, 2013.
DOI : 10.1016/j.jhep.2012.10.002

K. Takemoto, E. Hatano, K. Iwaisako, M. Takeiri, N. Noma et al., Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminopheninduced acute liver failure, FEBS Open Bio, vol.4, pp.777-787, 2014.
DOI : 10.1016/j.fob.2014.08.007
URL : https://febs.onlinelibrary.wiley.com/doi/pdf/10.1016/j.fob.2014.08.007

Y. F. Zhang, W. He, C. Zhang, X. J. Liu, Y. Lu et al., Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice, Toxicol Lett, vol.225, pp.445-453, 2014.

L. Dara, H. Johnson, J. Suda, S. Win, W. Gaarde et al., Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis, Hepatology, vol.62, pp.1847-1857, 2015.
DOI : 10.1002/hep.27939
URL : https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.27939

A. T. Schneider, J. Gautheron, F. Tacke, M. Vucur, and T. Luedde, Receptor interacting protein kinase-1 (RIPK1) in hepatocytes does not mediate murine acetaminophen toxicity, Hepatology, vol.64, pp.306-308, 2016.
DOI : 10.1002/hep.28225

T. Luedde, N. Beraza, V. Kotsikoris, G. Van-loo, A. Nenci et al., Deletion of NEMO/ IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma, Cancer Cell, vol.11, pp.119-132, 2007.

H. Ehlken, S. Krishna-subramanian, L. Ochoa-callejero, V. Kondylis, N. E. Nadi et al., Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout, Cell Death Differ, vol.21, pp.1721-1732, 2014.
DOI : 10.1038/cdd.2014.83
URL : https://www.nature.com/articles/cdd201483.pdf